Moisand Fitzgerald Tamayo’s CVS Health CVS Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-105	Closed	-$6.2K	–	625
2024 Q2	$6.2K	Hold	105	–	–	﹤0.01%	364
2024 Q1	$8.38K	Hold	105	–	–	﹤0.01%	331
2023 Q4	$8.29K	Hold	105	–	–	﹤0.01%	357
2023 Q3	$7.33K	Sell	105 -218	-67%	-$15.4K	﹤0.01%	376
2023 Q2	$22.3K	Hold	323	–	–	﹤0.01%	241
2023 Q1	$24K	Sell	323 -150	-32%	-$12.6K	0.01%	241
2022 Q4	$44.1K	Buy	473 +105	+29%	+$10.1K	0.01%	182
2022 Q3	$35K	Buy	368 +143	+64%	+$14.2K	0.01%	184
2022 Q2	$21K	Buy	225 +215	+2,150%	+$21K	0.01%	221
2022 Q1	$1K	Sell	10 -140	-93%	-$14.7K	﹤0.01%	450
2021 Q4	$15K	Hold	150	–	–	﹤0.01%	225
2021 Q3	$13K	Hold	150	–	–	﹤0.01%	230
2021 Q2	$13K	Hold	150	–	–	﹤0.01%	238
2021 Q1	$11K	Buy	+150	New	+$10.9K	﹤0.01%	205
2018 Q3	–	Sell	-250	Closed	-$16K	–	302
2018 Q2	$16K	Sell	250 -200	-44%	-$13.2K	0.01%	170
2018 Q1	$28K	Buy	450 +200	+80%	+$14.3K	0.02%	147
2017 Q4	$18K	Hold	250	–	–	0.01%	155
2017 Q3	$20K	Buy	+250	New	+$19.8K	0.01%	160
2016 Q1	–	Sell	-68	Closed	-$7K	–	231
2015 Q4	$7K	Buy	+68	New	+$6.66K	0.01%	161

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Moisand Fitzgerald Tamayo's CVS Position: Q3 2024 in Review

Moisand Fitzgerald Tamayo sold out of CVS Health (CVS) in Q3 2024, closing a stake of 105 shares — an estimated $6.2K sold.

Moisand Fitzgerald Tamayo first reported a position in CVS in Q4 2015 and held it in 19 quarters. The position peaked at $44.1K in Q4 2022. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Moisand Fitzgerald Tamayo reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Moisand Fitzgerald Tamayo sold 105 CVS Health shares in Q3 2024, an estimated $6.2K.
Moisand Fitzgerald Tamayo first reported a position in CVS Health in Q4 2015 and held it in 19 quarters.
Moisand Fitzgerald Tamayo's CVS Health position peaked at $44.1K in Q4 2022.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q3 2024, filed 9 Oct 2024.